{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "06", "@timestamp": "2024-11-06T14:53:45.000045-05:00", "@year": "2024", "@month": "11"}, "ait:date-sort": {"@day": "01", "@year": "2017", "@month": "12"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": {"xocs:funding-agency-matched-string": "Chulalongkorn University", "xocs:funding-agency-acronym": "CU", "xocs:funding-agency": "Chulalongkorn University", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/501100002873", "xocs:funding-agency-country": "http://sws.geonames.org/1605651/"}, "xocs:funding-addon-generated-timestamp": "2021-05-29T17:30:27.333Z", "xocs:funding-text": "A. Pugongchai was supported by the Chulalongkorn University Graduate Scholarship to Commemorate the 72nd Anniversary of His Majesty King Bhumibol Adulyadej.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pathology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "100287552"}, "@dptid": "100287552"}, "author": [{"ce:given-name": "Apiwat", "preferred-name": {"ce:given-name": "Apiwat", "ce:initials": "A.", "ce:surname": "Pugongchai", "ce:indexed-name": "Pugongchai A."}, "@seq": "1", "ce:initials": "A.", "@_fa": "true", "@type": "auth", "ce:surname": "Pugongchai", "@auid": "57200857222", "@orcid": "0000-0002-8077-9346", "ce:indexed-name": "Pugongchai A."}, {"ce:given-name": "Andrey", "preferred-name": {"ce:given-name": "Andrey", "ce:initials": "A.", "ce:surname": "Bychkov", "ce:indexed-name": "Bychkov A."}, "@seq": "2", "ce:initials": "A.", "@date-locked": "2024-07-03T07:38:56.475", "@_fa": "true", "@type": "auth", "ce:surname": "Bychkov", "@auid": "51763147200", "@orcid": "0000-0002-4203-5696", "ce:indexed-name": "Bychkov A."}, {"ce:given-name": "Pichet", "preferred-name": {"ce:given-name": "Pichet", "ce:initials": "P.", "ce:surname": "Sampatanukul", "ce:indexed-name": "Sampatanukul P."}, "@seq": "3", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Sampatanukul", "@auid": "6603555113", "@orcid": "0000-0002-7842-0895", "ce:indexed-name": "Sampatanukul P."}]}, "citation-title": "Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer", "abstracts": "\u00a9 2018 The Authors. International Journal of Experimental Pathology \u00a9 2018 International Journal of Experimental PathologyCurrently available tools for early diagnosis and prognosis of prostate cancer lack sufficient accuracy. There is a need to identify novel biomarkers for this common malignancy. SOX family genes play an important role in embryogenesis and are also implicated in various cancers. SOX11 has been recently recognized as a potential tumour suppressor that is downregulated in prostate cancer. We hypothesized that hypermethylation may be responsible for SOX11 silencing in human prostate cancer. The aim of the study was to investigate SOX11 promoter methylation in prostate adenocarcinoma by comparing it with benign prostatic hyperplasia (BPH). A total of 143 human prostate tissue samples, 62 from patients with prostate cancer and 81 from patients with BPH were examined by methylation-specific PCR. Associations between SOX11 promoter methylation and clinicopathological parameters were assessed by univariate statistics. Detection rates of SOX11 promoter methylation were 80.6% and 35.8% in prostate cancer and BPH respectively (P < 0.001). SOX11 hypermethylation was associated with adverse clinicopathological characteristics of prostate cancer, including higher PSA level (P < 0.01), Gleason score \u2265 7 (P = 0.03) and perineural invasion (P = 0.03). SOX11 methylation was positively correlated with the PSA level (P = 0.001). Our data indicated that SOX11 can be a promising methylation marker candidate for differential diagnosis and risk stratification for prostate cancer.", "correspondence": {"affiliation": {"country": "Thailand", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pathology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Pichet", "ce:initials": "P.", "ce:surname": "Sampatanukul", "ce:indexed-name": "Sampatanukul P."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "benign prostatic hyperplasia", "@xml:lang": "eng"}, {"$": "promoter methylation", "@xml:lang": "eng"}, {"$": "prostate cancer", "@xml:lang": "eng"}, {"$": "SOX11", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1365-2613", "@type": "email"}}, "translated-sourcetitle": {"$": "International Journal of Experimental Pathology", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "98", "@issue": "6"}, "pagerange": {"@first": "341", "@last": "346"}}, "@type": "j", "sourcetitle": "International Journal of Experimental Pathology", "publicationdate": {"month": "12", "year": "2017", "date-text": "December 2017", "day": "01"}, "codencode": "IJEPE", "sourcetitle-abbrev": "Int. J. Exp. Pathol.", "@country": "gbr", "issn": [{"$": "13652613", "@type": "electronic"}, {"$": "09599673", "@type": "print"}], "publicationyear": {"@first": "2017"}, "publisher": {"publishername": "Blackwell Publishing Ltd"}, "@srcid": "14751"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": [{"classification-code": "84.1.3.1", "classification-description": "GENETICS AND MOLECULAR BIOLOGY; MOLECULAR GENETICS; Modification and Restriction; DNA"}, {"classification-code": "84.5.13.2", "classification-description": "GENETICS AND MOLECULAR BIOLOGY; EUKARYOTIC GENETICS; Genetics and Cancer; Gene expression"}, {"classification-code": "87.2.9.2", "classification-description": "CANCER RESEARCH; TUMOUR BIOLOGY; Genetics; Gene expression"}, {"classification-code": "87.5.16", "classification-description": "CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Prostate"}, {"classification-code": "87.7", "classification-description": "CANCER RESEARCH; GENERAL CONCEPTS"}]}, {"@type": "EMCLASS", "classification": [{"classification-code": "16", "classification-description": "Cancer"}, {"classification-code": "28", "classification-description": "Urology and Nephrology"}, {"classification-code": "29", "classification-description": "Clinical and Experimental Biochemistry"}]}, {"@type": "ASJC", "classification": [{"$": "2734"}, {"$": "1312"}, {"$": "1307"}]}, {"@type": "SUBJABBR", "classification": [{"$": "MEDI"}, {"$": "BIOC"}]}]}, "chemicalgroup": {"chemicals": {"@source": "nlm", "chemical": [{"chemical-name": "SOX11 protein, human"}, {"chemical-name": "SOXC Transcription Factors"}]}}}, "grantlist": {"@complete": "y", "grant-text": {"$": "This study was approved by the Institutional Review Board of the Faculty of Medicine, Chulalongkorn University (IRB No. 440/59, Certificate of Approval CoA 763/2016).", "@xml:lang": "eng"}, "grant": {"grant-acronym": "CU", "grant-agency": {"@iso-code": "tha", "$": "Chulalongkorn University"}, "grant-agency-id": "501100002873"}}}, "item-info": {"copyright": {"$": "Copyright 2018 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "external-source": "MEDLINE", "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "MEDL"}, {"$": "REAXYSCAR"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "17", "@timestamp": "BST 15:33:10", "@year": "2018", "@month": "09"}}, "itemidlist": {"itemid": [{"$": "620907271", "@idtype": "PUI"}, {"$": "2018062076", "@idtype": "CABS"}, {"$": "909188320", "@idtype": "CAR-ID"}, {"$": "20180144087", "@idtype": "EMBASE"}, {"$": "29315911", "@idtype": "MEDL"}, {"$": "20180347995", "@idtype": "REAXYSCAR"}, {"$": "20180615416", "@idtype": "SCOPUS"}, {"$": "85042529228", "@idtype": "SCP"}, {"$": "85042529228", "@idtype": "SGR"}, {"$": "623877383", "@idtype": "PUIsecondary"}], "ce:doi": "10.1111/iep.12257"}}, "tail": {"bibliography": {"@refcount": "34", "reference": [{"ref-fulltext": "Bashir M.N. (2015) Epidemiology of prostate cancer. Asian Pac. J. Cancer Prev. 16, 5137\u20135141.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Epidemiology of prostate cancer"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0001", "@idtype": "FRAGMENTID"}, {"$": "84939426584", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "5137", "@last": "5141"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.N.", "@_fa": "true", "ce:surname": "Bashir", "ce:indexed-name": "Bashir M.N."}]}, "ref-sourcetitle": "Asian Pac. J. Cancer Prev."}}, {"ref-fulltext": "Baylin S.B. & Jones P.A. (2011) A decade of exploring the cancer epigenome - Biological and translational implications. Nat. Rev. Cancer 11, 726\u2013734.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "A decade of exploring the cancer epigenome - Biological and translational implications"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0002", "@idtype": "FRAGMENTID"}, {"$": "80053144962", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "726", "@last": "734"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.B.", "@_fa": "true", "ce:surname": "Baylin", "ce:indexed-name": "Baylin S.B."}, {"@seq": "2", "ce:initials": "P.A.", "@_fa": "true", "ce:surname": "Jones", "ce:indexed-name": "Jones P.A."}]}, "ref-sourcetitle": "Nat. Rev. Cancer"}}, {"ref-fulltext": "Bilir B., Osunkoya A.O., Wiles W.G. 4th et al. (2016) SOX4 is essential for prostate tumorigenesis initiated by PTEN ablation. Cancer Res. 76, 1112\u20131121.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "SOX4 is essential for prostate tumorigenesis initiated by PTEN ablation"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0003", "@idtype": "FRAGMENTID"}, {"$": "84961763366", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "76"}, "pagerange": {"@first": "1112", "@last": "1121"}}, "ref-text": "4th", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Bilir", "ce:indexed-name": "Bilir B."}, {"@seq": "2", "ce:initials": "A.O.", "@_fa": "true", "ce:surname": "Osunkoya", "ce:indexed-name": "Osunkoya A.O."}, {"@seq": "3", "ce:initials": "W.G.", "@_fa": "true", "ce:surname": "Wiles", "ce:indexed-name": "Wiles W.G."}], "et-al": null}, "ref-sourcetitle": "Cancer Res."}}, {"ref-fulltext": "Castillo S.D. & Sanchez-Cespedes M. (2012) The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Expert Opin. Ther. Targets 16, 903\u2013919.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "The SOX family of genes in cancer development: biological relevance and opportunities for therapy"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0004", "@idtype": "FRAGMENTID"}, {"$": "84865309439", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "16"}, "pagerange": {"@first": "903", "@last": "919"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.D.", "@_fa": "true", "ce:surname": "Castillo", "ce:indexed-name": "Castillo S.D."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Sanchez-Cespedes", "ce:indexed-name": "Sanchez-Cespedes M."}]}, "ref-sourcetitle": "Expert Opin. Ther. Targets"}}, {"ref-fulltext": "Ferlay J., Soerjomataram I., Ervik M. et al. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0005", "@idtype": "FRAGMENTID"}, {"$": "84892961071", "@idtype": "SGR"}]}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ferlay", "ce:indexed-name": "Ferlay J."}, {"@seq": "2", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Soerjomataram", "ce:indexed-name": "Soerjomataram I."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Ervik", "ce:indexed-name": "Ervik M."}], "et-al": null}, "ref-sourcetitle": "GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer"}}, {"ref-fulltext": "Goering W., Kloth M. & Schulz W.A. (2012) DNA methylation changes in prostate cancer. In: Cancer Epigenetics, pp. 47\u201366. (ed R.G. Dumitrescu & M. Verma), Clifton, NJ: Humana Press.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "DNA methylation changes in prostate cancer"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0006", "@idtype": "FRAGMENTID"}, {"$": "84859953293", "@idtype": "SGR"}]}, "ref-volisspag": {"pagerange": {"@first": "47", "@last": "66"}}, "ref-text": "&, In, (ed, R.G. Dumitrescu, &, M. Verma, Clifton, NJ, Humana Press", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Goering", "ce:indexed-name": "Goering W."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Kloth", "ce:indexed-name": "Kloth M."}, {"@seq": "3", "ce:initials": "W.A.", "@_fa": "true", "ce:surname": "Schulz", "ce:indexed-name": "Schulz W.A."}]}, "ref-sourcetitle": "Cancer Epigenetics"}}, {"ref-fulltext": "Greene K.L., Albertsen P.C., Babaian R.J. et al. (2009) Prostate specific antigen best practice statement: 2009 update. J. Urol. 182, 2232\u20132241.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Prostate specific antigen best practice statement: 2009 update"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0007", "@idtype": "FRAGMENTID"}, {"$": "70350450970", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "182"}, "pagerange": {"@first": "2232", "@last": "2241"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.L.", "@_fa": "true", "ce:surname": "Greene", "ce:indexed-name": "Greene K.L."}, {"@seq": "2", "ce:initials": "P.C.", "@_fa": "true", "ce:surname": "Albertsen", "ce:indexed-name": "Albertsen P.C."}, {"@seq": "3", "ce:initials": "R.J.", "@_fa": "true", "ce:surname": "Babaian", "ce:indexed-name": "Babaian R.J."}], "et-al": null}, "ref-sourcetitle": "J. Urol."}}, {"ref-fulltext": "Gustavsson E., Sernbo S., Andersson E. et al. (2010) SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies. Mol. Cancer. 9, 187.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "SOX11 expression correlates to promoter methylation and regulates tumor growth in hematopoietic malignancies"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0008", "@idtype": "FRAGMENTID"}, {"$": "77954392939", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "187"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Gustavsson", "ce:indexed-name": "Gustavsson E."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Sernbo", "ce:indexed-name": "Sernbo S."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Andersson", "ce:indexed-name": "Andersson E."}], "et-al": null}, "ref-sourcetitle": "Mol. Cancer."}}, {"ref-fulltext": "Hern\u00e1ndez J. & Thompson I.M. (2004) Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker. Cancer 101, 894\u2013904.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Prostate-specific antigen: a review of the validation of the most commonly used cancer biomarker"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0009", "@idtype": "FRAGMENTID"}, {"$": "4143148652", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "101"}, "pagerange": {"@first": "894", "@last": "904"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Hern\u00e1ndez", "ce:indexed-name": "Hernandez J."}, {"@seq": "2", "ce:initials": "I.M.", "@_fa": "true", "ce:surname": "Thompson", "ce:indexed-name": "Thompson I.M."}]}, "ref-sourcetitle": "Cancer"}}, {"ref-fulltext": "Hide T., Takezaki T., Nakatani Y., Nakamura H., Kuratsu J., Kondo T. (2009) SOX11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation. Cancer Res. 69, 7953\u20137959.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "SOX11 prevents tumorigenesis of glioma-initiating cells by inducing neuronal differentiation"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0010", "@idtype": "FRAGMENTID"}, {"$": "70350660817", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "69"}, "pagerange": {"@first": "7953", "@last": "7959"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Hide", "ce:indexed-name": "Hide T."}, {"@seq": "2", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Takezaki", "ce:indexed-name": "Takezaki T."}, {"@seq": "3", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Nakatani", "ce:indexed-name": "Nakatani Y."}, {"@seq": "4", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Nakamura", "ce:indexed-name": "Nakamura H."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Kuratsu", "ce:indexed-name": "Kuratsu J."}, {"@seq": "6", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Kondo", "ce:indexed-name": "Kondo T."}]}, "ref-sourcetitle": "Cancer Res."}}, {"ref-fulltext": "Huang Z., Bassil C.F., Murphy S.K. (2013) Methylation-specific PCR. Methods Mol. Biol. 1049, 75\u201382.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Methylation-specific PCR"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0011", "@idtype": "FRAGMENTID"}, {"$": "84881570128", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "1049"}, "pagerange": {"@first": "75", "@last": "82"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Huang", "ce:indexed-name": "Huang Z."}, {"@seq": "2", "ce:initials": "C.F.", "@_fa": "true", "ce:surname": "Bassil", "ce:indexed-name": "Bassil C.F."}, {"@seq": "3", "ce:initials": "S.K.", "@_fa": "true", "ce:surname": "Murphy", "ce:indexed-name": "Murphy S.K."}]}, "ref-sourcetitle": "Methods Mol. Biol."}}, {"ref-fulltext": "Humphrey P.A. (2004) Gleason grading and prognostic factors in carcinoma of the prostate. Mod. Pathol. 17, 292\u2013306.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Gleason grading and prognostic factors in carcinoma of the prostate"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0012", "@idtype": "FRAGMENTID"}, {"$": "7444271447", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "17"}, "pagerange": {"@first": "292", "@last": "306"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.A.", "@_fa": "true", "ce:surname": "Humphrey", "ce:indexed-name": "Humphrey P.A."}]}, "ref-sourcetitle": "Mod. Pathol."}}, {"ref-fulltext": "Hyodo-Miura J., Urushiyama S., Nagai S., Nishita M., Ueno N. & Shibuya H. (2002) Involvement of NLK and Sox11 in neural induction in Xenopus development. Genes Cells 7, 487\u2013496.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Involvement of NLK and Sox11 in neural induction in Xenopus development"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0013", "@idtype": "FRAGMENTID"}, {"$": "0036100224", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "487", "@last": "496"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Hyodo-Miura", "ce:indexed-name": "Hyodo-Miura J."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Urushiyama", "ce:indexed-name": "Urushiyama S."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Nagai", "ce:indexed-name": "Nagai S."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Nishita", "ce:indexed-name": "Nishita M."}, {"@seq": "5", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ueno", "ce:indexed-name": "Ueno N."}, {"@seq": "6", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Shibuya", "ce:indexed-name": "Shibuya H."}]}, "ref-sourcetitle": "Genes Cells"}}, {"ref-fulltext": "Kristensen H., Haldrup C., Strand S. et al. (2014) Hypermethylation of the GABRE miR-452 miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy. Clin. Cancer Res. 20, 2169\u20132181.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Hypermethylation of the GABRE miR-452 miR-224 promoter in prostate cancer predicts biochemical recurrence after radical prostatectomy"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0014", "@idtype": "FRAGMENTID"}, {"$": "84899013734", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "2169", "@last": "2181"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Kristensen", "ce:indexed-name": "Kristensen H."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Haldrup", "ce:indexed-name": "Haldrup C."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Strand", "ce:indexed-name": "Strand S."}], "et-al": null}, "ref-sourcetitle": "Clin. Cancer Res."}}, {"ref-fulltext": "Li L.C. & Dahiya R. (2002) MethPrimer: designing primers for methylation PCRs. Bioinformatics 18, 1427\u20131431.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "MethPrimer: designing primers for methylation PCRs"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0015", "@idtype": "FRAGMENTID"}, {"$": "0036856355", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "18"}, "pagerange": {"@first": "1427", "@last": "1431"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.C.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li L.C."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Dahiya", "ce:indexed-name": "Dahiya R."}]}, "ref-sourcetitle": "Bioinformatics"}}, {"ref-fulltext": "McKee T.C., Tricoli J.V. (2015) Epigenetics of prostate cancer. Methods Mol. Biol. 1238, 217\u2013234.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Epigenetics of prostate cancer"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0016", "@idtype": "FRAGMENTID"}, {"$": "84921741922", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "1238"}, "pagerange": {"@first": "217", "@last": "234"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "T.C.", "@_fa": "true", "ce:surname": "McKee", "ce:indexed-name": "McKee T.C."}, {"@seq": "2", "ce:initials": "J.V.", "@_fa": "true", "ce:surname": "Tricoli", "ce:indexed-name": "Tricoli J.V."}]}, "ref-sourcetitle": "Methods Mol. Biol."}}, {"ref-fulltext": "Mozos A., Royo C., Hartmann E. et al. (2009) SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype. Haematologica 94, 1555\u20131562.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0017", "@idtype": "FRAGMENTID"}, {"$": "70449435195", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "94"}, "pagerange": {"@first": "1555", "@last": "1562"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Mozos", "ce:indexed-name": "Mozos A."}, {"@seq": "2", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Royo", "ce:indexed-name": "Royo C."}, {"@seq": "3", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Hartmann", "ce:indexed-name": "Hartmann E."}], "et-al": null}, "ref-sourcetitle": "Haematologica"}}, {"ref-fulltext": "Nygren L., Wennerholm S.B., Klimkowska M., Christensson B., Kimby E. & Sander B. (2012) Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma. Blood 119, 4215\u20134223.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Prognostic role of SOX11 in a population-based cohort of mantle cell lymphoma"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0018", "@idtype": "FRAGMENTID"}, {"$": "84860830052", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "119"}, "pagerange": {"@first": "4215", "@last": "4223"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Nygren", "ce:indexed-name": "Nygren L."}, {"@seq": "2", "ce:initials": "S.B.", "@_fa": "true", "ce:surname": "Wennerholm", "ce:indexed-name": "Wennerholm S.B."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Klimkowska", "ce:indexed-name": "Klimkowska M."}, {"@seq": "4", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Christensson", "ce:indexed-name": "Christensson B."}, {"@seq": "5", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Kimby", "ce:indexed-name": "Kimby E."}, {"@seq": "6", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Sander", "ce:indexed-name": "Sander B."}]}, "ref-sourcetitle": "Blood"}}, {"ref-fulltext": "Pan J., Chen J., Zhang B. et al. (2013) Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis. PLoS ONE 8, e75283.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Association between RASSF1A promoter methylation and prostate cancer: a systematic review and meta-analysis"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0019", "@idtype": "FRAGMENTID"}, {"$": "e75283", "@idtype": "ARTNUM"}, {"$": "84884493084", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "8"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Pan", "ce:indexed-name": "Pan J."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen J."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang B."}], "et-al": null}, "ref-sourcetitle": "PLoS ONE"}}, {"ref-fulltext": "Park J.Y. (2015) Promoter hypermethylation as a biomarker in prostate adenocarcinoma. In: Cancer Epigenetics: risk Assessment, Diagnosis, Treatment, and Prognosis, pp. 607\u2013625. (ed M. Verma), New York: Springer.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Promoter hypermethylation as a biomarker in prostate adenocarcinoma"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0020", "@idtype": "FRAGMENTID"}, {"$": "84921807799", "@idtype": "SGR"}]}, "ref-volisspag": {"pagerange": {"@first": "607", "@last": "625"}}, "ref-text": "In, (ed, M. Verma, New York, Springer", "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.Y.", "@_fa": "true", "ce:surname": "Park", "ce:indexed-name": "Park J.Y."}]}, "ref-sourcetitle": "Cancer Epigenetics: risk Assessment, Diagnosis, Treatment, and Prognosis"}}, {"ref-fulltext": "Patel A.A., Chen M.H., Renshaw A.A. & D'Amico A.V. (2007) PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5. JAMA 298, 1533\u20131538.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0021", "@idtype": "FRAGMENTID"}, {"$": "34948888715", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "298"}, "pagerange": {"@first": "1533", "@last": "1538"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Patel", "ce:indexed-name": "Patel A.A."}, {"@seq": "2", "ce:initials": "M.H.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen M.H."}, {"@seq": "3", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Renshaw", "ce:indexed-name": "Renshaw A.A."}, {"@seq": "4", "ce:initials": "A.V.", "@_fa": "true", "ce:surname": "D'Amico", "ce:indexed-name": "D'Amico A.V."}]}, "ref-sourcetitle": "JAMA"}}, {"ref-fulltext": "Richiardi L., Fiano V., Vizzini L. et al. (2009) Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients. J. Clin. Oncol. 27, 3161\u20133168.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Promoter methylation in APC, RUNX3, and GSTP1 and mortality in prostate cancer patients"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0022", "@idtype": "FRAGMENTID"}, {"$": "67650340970", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "27"}, "pagerange": {"@first": "3161", "@last": "3168"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Richiardi", "ce:indexed-name": "Richiardi L."}, {"@seq": "2", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Fiano", "ce:indexed-name": "Fiano V."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Vizzini", "ce:indexed-name": "Vizzini L."}], "et-al": null}, "ref-sourcetitle": "J. Clin. Oncol."}}, {"ref-fulltext": "Sernbo S., Gustavsson E., Brennan D.J. et al. (2011) The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation. BMC Cancer 11, 405.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "The tumour suppressor SOX11 is associated with improved survival among high grade epithelial ovarian cancers and is regulated by reversible promoter methylation"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0023", "@idtype": "FRAGMENTID"}, {"$": "80053173700", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "11"}, "pagerange": {"@first": "405"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Sernbo", "ce:indexed-name": "Sernbo S."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Gustavsson", "ce:indexed-name": "Gustavsson E."}, {"@seq": "3", "ce:initials": "D.J.", "@_fa": "true", "ce:surname": "Brennan", "ce:indexed-name": "Brennan D.J."}], "et-al": null}, "ref-sourcetitle": "BMC Cancer"}}, {"ref-fulltext": "Strand S., Orntoft T.F. & Sorensen K.D. (2014) Prognostic DNA methylation markers for prostate cancer. Int. J. Mol. Sci. 15, 16544\u201316576.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Prognostic DNA methylation markers for prostate cancer"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0024", "@idtype": "FRAGMENTID"}, {"$": "84907863142", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "15"}, "pagerange": {"@first": "16544", "@last": "16576"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Strand", "ce:indexed-name": "Strand S."}, {"@seq": "2", "ce:initials": "T.F.", "@_fa": "true", "ce:surname": "Orntoft", "ce:indexed-name": "Orntoft T.F."}, {"@seq": "3", "ce:initials": "K.D.", "@_fa": "true", "ce:surname": "Sorensen", "ce:indexed-name": "Sorensen K.D."}]}, "ref-sourcetitle": "Int. J. Mol. Sci."}}, {"ref-fulltext": "Strand S.H., Switnicki M., Moller M. et al. (2015) RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy. Oncotarget 8, 5774\u20135788.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0025", "@idtype": "FRAGMENTID"}, {"$": "85010715537", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "8"}, "pagerange": {"@first": "5774", "@last": "5788"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.H.", "@_fa": "true", "ce:surname": "Strand", "ce:indexed-name": "Strand S.H."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Switnicki", "ce:indexed-name": "Switnicki M."}, {"@seq": "3", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Moller", "ce:indexed-name": "Moller M."}], "et-al": null}, "ref-sourcetitle": "Oncotarget"}}, {"ref-fulltext": "Turker M.S., Swisshelm K., Smith A.C. & Martin G.M. (1989) A partial methylation profile for a CpG site is stably maintained in mammalian tissues and cultured cell lines. J. Biol. Chem. 264, 11632\u201311636.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "1989"}, "ref-title": {"ref-titletext": "A partial methylation profile for a CpG site is stably maintained in mammalian tissues and cultured cell lines"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0026", "@idtype": "FRAGMENTID"}, {"$": "0024405205", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "264"}, "pagerange": {"@first": "11632", "@last": "11636"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.S.", "@_fa": "true", "ce:surname": "Turker", "ce:indexed-name": "Turker M.S."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Swisshelm", "ce:indexed-name": "Swisshelm K."}, {"@seq": "3", "ce:initials": "A.C.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith A.C."}, {"@seq": "4", "ce:initials": "G.M.", "@_fa": "true", "ce:surname": "Martin", "ce:indexed-name": "Martin G.M."}]}, "ref-sourcetitle": "J. Biol. Chem."}}, {"ref-fulltext": "Wang Y., Lin L., Lai H., Parada L.F. & Lei L. (2013) Transcription factor Sox11 is essential for both embryonic and adult neurogenesis. Dev. Dyn. 242, 638\u2013653.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Transcription factor Sox11 is essential for both embryonic and adult neurogenesis"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0027", "@idtype": "FRAGMENTID"}, {"$": "84878147851", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "242"}, "pagerange": {"@first": "638", "@last": "653"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang Y."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Lin", "ce:indexed-name": "Lin L."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Lai", "ce:indexed-name": "Lai H."}, {"@seq": "4", "ce:initials": "L.F.", "@_fa": "true", "ce:surname": "Parada", "ce:indexed-name": "Parada L.F."}, {"@seq": "5", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Lei", "ce:indexed-name": "Lei L."}]}, "ref-sourcetitle": "Dev. Dyn."}}, {"ref-fulltext": "Weina K. & Utikal J. (2014) SOX2 and cancer: current research and its implications in the clinic. Clin. Transl. Med. 3, 19.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "SOX2 and cancer: current research and its implications in the clinic"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0028", "@idtype": "FRAGMENTID"}, {"$": "84921776917", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "3"}, "pagerange": {"@first": "19"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Weina", "ce:indexed-name": "Weina K."}, {"@seq": "2", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Utikal", "ce:indexed-name": "Utikal J."}]}, "ref-sourcetitle": "Clin. Transl. Med."}}, {"ref-fulltext": "Wilson M. & Koopman P. (2002) Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators. Curr. Opin. Genet. Dev. 12, 441\u2013446.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2002"}, "ref-title": {"ref-titletext": "Matching SOX: partner proteins and co-factors of the SOX family of transcriptional regulators"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0029", "@idtype": "FRAGMENTID"}, {"$": "0036668285", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "441", "@last": "446"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Wilson", "ce:indexed-name": "Wilson M."}, {"@seq": "2", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Koopman", "ce:indexed-name": "Koopman P."}]}, "ref-sourcetitle": "Curr. Opin. Genet. Dev."}}, {"ref-fulltext": "Xu X., Chang X., Li Z. et al. (2015) Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer. Cell Oncol. (Dordr.) 38, 183\u2013194.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Aberrant SOX11 promoter methylation is associated with poor prognosis in gastric cancer"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0030", "@idtype": "FRAGMENTID"}, {"$": "84929946072", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "38"}, "pagerange": {"@first": "183", "@last": "194"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Xu", "ce:indexed-name": "Xu X."}, {"@seq": "2", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Chang", "ce:indexed-name": "Chang X."}, {"@seq": "3", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li Z."}], "et-al": null}, "ref-sourcetitle": "Cell Oncol. (Dordr.)"}}, {"ref-fulltext": "Yao Z., Sun B., Hong Q. et al. (2015) The role of tumor suppressor gene SOX11 in prostate cancer. Tumour Biol. 36, 6133\u20136138.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "The role of tumor suppressor gene SOX11 in prostate cancer"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0031", "@idtype": "FRAGMENTID"}, {"$": "84940439070", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "36"}, "pagerange": {"@first": "6133", "@last": "6138"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Z.", "@_fa": "true", "ce:surname": "Yao", "ce:indexed-name": "Yao Z."}, {"@seq": "2", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Sun", "ce:indexed-name": "Sun B."}, {"@seq": "3", "ce:initials": "Q.", "@_fa": "true", "ce:surname": "Hong", "ce:indexed-name": "Hong Q."}], "et-al": null}, "ref-sourcetitle": "Tumour Biol."}}, {"ref-fulltext": "Yoon H.Y., Kim Y.W., Kang H.W. et al. (2012) DNA methylation of GSTP1 in human prostate tissues: pyrosequencing analysis. Korean J. Urol. 53, 200\u2013205.", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "DNA methylation of GSTP1 in human prostate tissues: pyrosequencing analysis"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0032", "@idtype": "FRAGMENTID"}, {"$": "84930486268", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "53"}, "pagerange": {"@first": "200", "@last": "205"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.Y.", "@_fa": "true", "ce:surname": "Yoon", "ce:indexed-name": "Yoon H.Y."}, {"@seq": "2", "ce:initials": "Y.W.", "@_fa": "true", "ce:surname": "Kim", "ce:indexed-name": "Kim Y.W."}, {"@seq": "3", "ce:initials": "H.W.", "@_fa": "true", "ce:surname": "Kang", "ce:indexed-name": "Kang H.W."}], "et-al": null}, "ref-sourcetitle": "Korean J. Urol."}}, {"ref-fulltext": "Zhang S., Li S. & Gao J.L. (2013) Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma. Cancer Cell Int. 13, 109.", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Promoter methylation status of the tumor suppressor gene SOX11 is associated with cell growth and invasion in nasopharyngeal carcinoma"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0033", "@idtype": "FRAGMENTID"}, {"$": "84887122136", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "13"}, "pagerange": {"@first": "109"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Zhang", "ce:indexed-name": "Zhang S."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li S."}, {"@seq": "3", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Gao", "ce:indexed-name": "Gao J.L."}]}, "ref-sourcetitle": "Cancer Cell Int."}}, {"ref-fulltext": "Zhong W.D., Qin G.Q., Dai Q.S. et al. (2012) SOXs in human prostate cancer: implication as progression and prognosis factors. BMC Cancer 12, 248.", "@id": "34", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "SOXs in human prostate cancer: implication as progression and prognosis factors"}, "refd-itemidlist": {"itemid": [{"$": "iep12257-cit-0034", "@idtype": "FRAGMENTID"}, {"$": "84862160498", "@idtype": "SGR"}]}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "248"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.D.", "@_fa": "true", "ce:surname": "Zhong", "ce:indexed-name": "Zhong W.D."}, {"@seq": "2", "ce:initials": "G.Q.", "@_fa": "true", "ce:surname": "Qin", "ce:indexed-name": "Qin G.Q."}, {"@seq": "3", "ce:initials": "Q.S.", "@_fa": "true", "ce:surname": "Dai", "ce:indexed-name": "Dai Q.S."}], "et-al": null}, "ref-sourcetitle": "BMC Cancer"}}]}}}}, "affiliation": {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, "coredata": {"srctype": "j", "eid": "2-s2.0-85042529228", "dc:description": "Currently available tools for early diagnosis and prognosis of prostate cancer lack sufficient accuracy. There is a need to identify novel biomarkers for this common malignancy. SOX family genes play an important role in embryogenesis and are also implicated in various cancers. SOX11 has been recently recognized as a potential tumour suppressor that is downregulated in prostate cancer. We hypothesized that hypermethylation may be responsible for SOX11 silencing in human prostate cancer. The aim of the study was to investigate SOX11 promoter methylation in prostate adenocarcinoma by comparing it with benign prostatic hyperplasia (BPH). A total of 143 human prostate tissue samples, 62 from patients with prostate cancer and 81 from patients with BPH were examined by methylation-specific PCR. Associations between SOX11 promoter methylation and clinicopathological parameters were assessed by univariate statistics. Detection rates of SOX11 promoter methylation were 80.6% and 35.8% in prostate cancer and BPH respectively (P < 0.001). SOX11 hypermethylation was associated with adverse clinicopathological characteristics of prostate cancer, including higher PSA level (P < 0.01), Gleason score \u2265 7 (P = 0.03) and perineural invasion (P = 0.03). SOX11 methylation was positively correlated with the PSA level (P = 0.001). Our data indicated that SOX11 can be a promising methylation marker candidate for differential diagnosis and risk stratification for prostate cancer.", "pubmed-id": "29315911", "prism:coverDate": "2017-12-01", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/85042529228", "dc:creator": {"author": [{"ce:given-name": "Apiwat", "preferred-name": {"ce:given-name": "Apiwat", "ce:initials": "A.", "ce:surname": "Pugongchai", "ce:indexed-name": "Pugongchai A."}, "@seq": "1", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Pugongchai", "@auid": "57200857222", "author-url": "https://api.elsevier.com/content/author/author_id/57200857222", "ce:indexed-name": "Pugongchai A."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/85042529228"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85042529228&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=85042529228&origin=inward"}], "source-id": "14751", "citedby-count": "13", "prism:volume": "98", "subtype": "ar", "dc:title": "Promoter hypermethylation of SOX11 correlates with adverse clinicopathological features of human prostate cancer", "openaccess": "2", "prism:issn": "13652613 09599673", "publishercopyright": "\u00a9 2018 The Authors. International Journal of Experimental Pathology \u00a9 2018 International Journal of Experimental Pathology", "prism:issueIdentifier": "6", "subtypeDescription": "Article", "prism:publicationName": "International Journal of Experimental Pathology", "prism:pageRange": "341-346", "prism:endingPage": "346", "openaccessFlag": null, "prism:doi": "10.1111/iep.12257", "prism:startingPage": "341", "dc:identifier": "SCOPUS_ID:85042529228", "dc:publisher": "Blackwell Publishing Ltd"}, "idxterms": {"mainterm": [{"$": "Aged", "@weight": "b", "@candidate": "n"}, {"$": "Cell Line, Tumor", "@weight": "b", "@candidate": "n"}, {"$": "DNA Methylation", "@weight": "b", "@candidate": "n"}, {"$": "Gene Expression Regulation, Neoplastic", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Male", "@weight": "b", "@candidate": "n"}, {"$": "Middle Aged", "@weight": "b", "@candidate": "n"}, {"$": "Promoter Regions, Genetic", "@weight": "b", "@candidate": "n"}, {"$": "Prostatic Hyperplasia", "@weight": "b", "@candidate": "n"}, {"$": "Prostatic Neoplasms", "@weight": "b", "@candidate": "n"}, {"$": "SOXC Transcription Factors", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "benign prostatic hyperplasia"}, {"@_fa": "true", "$": "promoter methylation"}, {"@_fa": "true", "$": "prostate cancer"}, {"@_fa": "true", "$": "SOX11"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Pathology and Forensic Medicine", "@code": "2734", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Molecular Biology", "@code": "1312", "@abbrev": "BIOC"}, {"@_fa": "true", "$": "Cell Biology", "@code": "1307", "@abbrev": "BIOC"}]}, "authors": {"author": [{"ce:given-name": "Apiwat", "preferred-name": {"ce:given-name": "Apiwat", "ce:initials": "A.", "ce:surname": "Pugongchai", "ce:indexed-name": "Pugongchai A."}, "@seq": "1", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Pugongchai", "@auid": "57200857222", "author-url": "https://api.elsevier.com/content/author/author_id/57200857222", "ce:indexed-name": "Pugongchai A."}, {"ce:given-name": "Andrey", "preferred-name": {"ce:given-name": "Andrey", "ce:initials": "A.", "ce:surname": "Bychkov", "ce:indexed-name": "Bychkov A."}, "@seq": "2", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Bychkov", "@auid": "51763147200", "author-url": "https://api.elsevier.com/content/author/author_id/51763147200", "ce:indexed-name": "Bychkov A."}, {"ce:given-name": "Pichet", "preferred-name": {"ce:given-name": "Pichet", "ce:initials": "P.", "ce:surname": "Sampatanukul", "ce:indexed-name": "Sampatanukul P."}, "@seq": "3", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Sampatanukul", "@auid": "6603555113", "author-url": "https://api.elsevier.com/content/author/author_id/6603555113", "ce:indexed-name": "Sampatanukul P."}]}}}